BlackRock has announced the upcoming liquidation of several U.S.-domiciled mutual funds and ETFs, including the BlackRock Health Sciences Trust, as part of its ongoing assessment to meet investors' evolving needs. The liquidation process involves 14 funds in total, with specific liquidation dates provided for each. Investors in these funds will continue to incur management fees until the liquidations are finalized, and those opting to sell their ETFs will also bear transaction and commission costs. This move is part of BlackRock's broader strategy to align its investment offerings with client objectives, leveraging its expansive platform to manage over $1 trillion in sustainable and transition investing assets globally.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.